Tag: Innosyn
-
Gamma-Valerolactone from Bio-Based Levulinic Acid as Alternative to Gamma Butyrolactone by Dr Marijn Rijkers
InnoSyn, founded on May 1st, 2017, is an R&D services spin-off from DSM to specifically focus on chemical programs to go: levulinic acid, fatty acid building blocks, lignin valorization and BIOFOREVER, the EU BBI project.
Written by
·